ADC Therapeutics (ADCT) Return on Sales (2021 - 2026)
ADC Therapeutics (ADCT) posted quarterly Return on Sales of 0.02% for Q1 2026, little changed year-on-year from 0.02% in Q1 2025, and up 36.6% on a QoQ basis from 0.02% in Q3 2025.
ADC Therapeutics (ADCT) Return on Sales (2021 - 2026) Analysis & Trends
ADC Therapeutics (ADCT) has reported Return on Sales for 6 consecutive years, with 0.02% the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.03% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.03% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.04% |
| Mar 31, 2022 | 0.00% |
| Sep 30, 2021 | -0.05% |
| Jun 30, 2021 | -0.19% |